Supplementary Figure S2 from KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

Autor: Peter Reichardt, Tommi Pesonen, Raija Kallio, Bengt Nilsson, Sebastian Bauer, Lars H. Lindner, Philipp J. Jost, Harri Sihto, Peter Hohenberger, Silke Cameron, Jochen Schütte, Kirsten Sundby Hall, Annette Reichardt, Mikael Eriksson, Eva Wardelmann, Heikki Joensuu
Rok vydání: 2023
Popis: Kaplan-Meier estimates of recurrence-free survival of patients with KIT exon 11 substitution mutation (A) and patients with KIT exon 9 mutation (B). The 5-year and 10-year survival rates are shown. Censored patients are indicated with a bar
Databáze: OpenAIRE